InnovAge Holding Business Summary

InnovAge Holding Corp. (INNV) operates a vertically integrated payer-provider platform specifically designed for the Program of All-inclusive Care for the Elderly (PACE). The company generates revenue primarily through fixed monthly capitation payments from Medicare and Medicaid, assuming full financial risk for the comprehensive medical and social needs of frail, dual-eligible seniors. Its business model centers on managing care through 20 owned and operated centers across six states, utilizing an interdisciplinary team to provide clinical care, physical therapy, and social services. By shifting care from high-cost institutional settings to community-based environments, InnovAge aims to capture the spread between government capitation rates and actual medical expenses. Within the competitive landscape, the company faces pressure from home health and value-based care providers such as Addus HomeCare, Aveanna Healthcare, and Astrana Health. InnovAge distinguishes itself as the only scaled, multi-state PACE platform, maintaining a dominant market share in a highly regulated niche that benefits from bipartisan support for aging-in-place initiatives. Leadership is currently spearheaded by CEO Patrick Blair, who joined in 2022 following senior executive roles at Anthem (now Elevance Health) and BAYADA Home Health Care. The executive team includes CFO Benjamin Adams, Chief Medical Officer Paul Taheri—who previously served as CEO of Yale Medicine—and Chief Strategy Officer Matt Huray. The company’s governance is heavily influenced by its private equity heritage; it transitioned from a non-profit founded in 1989 to a for-profit entity in 2016 following a majority investment by Welsh, Carson, Anderson & Stowe (WCAS). As of early 2026, the Board is chaired by Tom Scully, a General Partner at WCAS and former Administrator of the Centers for Medicare & Medicaid Services (CMS). Other notable board representation includes directors from Apax Partners, which remains a significant institutional shareholder alongside WCAS, ensuring a leadership pedigree deeply rooted in federal healthcare policy and private equity-backed healthcare scaling.